JP2002513409A5 - - Google Patents

Download PDF

Info

Publication number
JP2002513409A5
JP2002513409A5 JP1998538798A JP53879898A JP2002513409A5 JP 2002513409 A5 JP2002513409 A5 JP 2002513409A5 JP 1998538798 A JP1998538798 A JP 1998538798A JP 53879898 A JP53879898 A JP 53879898A JP 2002513409 A5 JP2002513409 A5 JP 2002513409A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998538798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002513409A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/004299 external-priority patent/WO1998039329A1/en
Publication of JP2002513409A publication Critical patent/JP2002513409A/ja
Publication of JP2002513409A5 publication Critical patent/JP2002513409A5/ja
Ceased legal-status Critical Current

Links

JP53879898A 1997-03-04 1998-03-04 アミド芳香環スルホンアミドヒドロキサム酸化合物 Ceased JP2002513409A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3979597P 1997-03-04 1997-03-04
US60/039,795 1997-03-04
PCT/US1998/004299 WO1998039329A1 (en) 1997-03-04 1998-03-04 Amidoaromatic ring sulfonamide hydroxamic acid compounds

Publications (2)

Publication Number Publication Date
JP2002513409A JP2002513409A (ja) 2002-05-08
JP2002513409A5 true JP2002513409A5 (https=) 2005-11-10

Family

ID=21907383

Family Applications (2)

Application Number Title Priority Date Filing Date
JP53879798A Abandoned JP2002513408A (ja) 1997-03-04 1998-03-04 チオールスルホンアミドヒドロキサム酸化合物
JP53879898A Ceased JP2002513409A (ja) 1997-03-04 1998-03-04 アミド芳香環スルホンアミドヒドロキサム酸化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP53879798A Abandoned JP2002513408A (ja) 1997-03-04 1998-03-04 チオールスルホンアミドヒドロキサム酸化合物

Country Status (10)

Country Link
US (1) US6451791B1 (https=)
EP (2) EP0983267B1 (https=)
JP (2) JP2002513408A (https=)
AT (2) ATE287885T1 (https=)
CA (2) CA2285405A1 (https=)
DE (2) DE69827940T2 (https=)
DK (2) DK0977745T3 (https=)
ES (2) ES2236893T3 (https=)
PT (1) PT983267E (https=)
WO (1) WO1998039329A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6747027B1 (en) 1996-07-22 2004-06-08 Pharmacia Corporation Thiol sulfonamide metalloprotease inhibitors
US6313123B1 (en) 1999-01-27 2001-11-06 American Cyanamid Company Acetylenic sulfonamide thiol tace inhibitors
US6946473B2 (en) 1999-01-27 2005-09-20 Wyeth Holdings Corporation Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
BR0007784A (pt) 1999-01-27 2002-02-05 American Cyanamid Co Composto, método para inibir mudanças patológicas mediadas pela enzima que converte o tnf-alfa (tace) em um mamìfero, composição farmacêutica, e, processo para preparar um composto
US6277885B1 (en) 1999-01-27 2001-08-21 American Cyanamid Company Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
US6753337B2 (en) 1999-01-27 2004-06-22 Wyeth Holdings Corporation Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
US6762178B2 (en) 1999-01-27 2004-07-13 Wyeth Holdings Corporation Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
US6340691B1 (en) 1999-01-27 2002-01-22 American Cyanamid Company Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
US6326516B1 (en) 1999-01-27 2001-12-04 American Cyanamid Company Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
US6225311B1 (en) 1999-01-27 2001-05-01 American Cyanamid Company Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
US6200996B1 (en) 1999-01-27 2001-03-13 American Cyanamid Company Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
US6800646B1 (en) 1999-02-08 2004-10-05 Pharmacia Corporation Sulfamato hydroxamic acid metalloprotease inhibitor
US6869951B1 (en) * 1999-07-16 2005-03-22 Pharmacia Corporation Method of changing conformation of a matrix metalloproteinase
AU6049800A (en) * 1999-07-16 2001-02-05 G.D. Searle & Co. Method of changing conformation of a matrix metalloproteinase
EP1088815A1 (en) 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutically active sulfonyl amino acid derivatives
US6696456B1 (en) 1999-10-14 2004-02-24 The Procter & Gamble Company Beta disubstituted metalloprotease inhibitors
BR0014759A (pt) * 1999-10-14 2002-07-02 Procter & Gamble Inibidores de metaloprotease beta dissubstituìdos
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
IL151250A0 (en) 2000-03-21 2003-04-10 Procter & Gamble Difluorobutyric acid metalloprotease inhibitors
EP1265864A1 (en) * 2000-03-21 2002-12-18 The Procter & Gamble Company Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
AU2000265100A1 (en) * 2000-07-12 2002-01-21 G.D. Searle And Co. N sulfonyl aminoacid derivatives as inhibitors of metalloproteinase
PH12012502440A1 (en) 2001-06-26 2013-06-17 Amgen Inc Antibodies to opgl
JP2005507937A (ja) 2001-11-01 2005-03-24 ワイス・ホールディングズ・コーポレイション マトリックスメタロプロテイナーゼおよびtace阻害剤としてのアレンアリールスルホンアミドヒドロキサム酸
MXPA04010555A (es) 2002-04-25 2005-02-17 Pharmacia Corp Acidos piperidinil- y piperazinil-sulfonilmetil hidroxamicos y su uso como inhibidores de proteasa.
MXPA04011767A (es) 2002-05-29 2005-03-31 Merck & Co Inc COMPUESTOS UTILES EN EL TRATAMIENTO DE áNTRAX E INHIBIDORES DEL FACTOR LETAL.
US7199155B2 (en) 2002-12-23 2007-04-03 Wyeth Holdings Corporation Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP1747212A4 (en) 2004-05-11 2009-03-25 Merck & Co Inc PROCESS FOR THE PREPARATION OF N-SULFONATED AMINOIC DERIVATIVES
EP1953148B1 (en) * 2005-10-28 2012-02-29 Takeda Pharmaceutical Company Limited Heterocyclic amide compound and use thereof
BRPI0709677A2 (pt) * 2006-03-29 2011-07-19 Novartis Ag inibidores seletivos das mmp à base de hidroxamato
EP2149568A1 (en) 2008-07-22 2010-02-03 Bracco Imaging S.p.A Aryl-sulphonamidic dimers as metalloproteases inhibitors
EP2147684A1 (en) * 2008-07-22 2010-01-27 Bracco Imaging S.p.A Diagnostic Agents Selective Against Metalloproteases
US9023318B2 (en) 2011-06-08 2015-05-05 Siemens Medical Solutions Usa, Inc. Compounds with matrix-metalloproteinase inhibitory activity and imaging agents thereof
RU2748835C1 (ru) 2017-11-27 2021-05-31 Совет Научных И Прикладных Исследований Индол(сульфонил)-n-гидроксибензамидные производные в качестве селективных ингибиторов hdac

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
US5455258A (en) 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5506242A (en) 1993-01-06 1996-04-09 Ciba-Geigy Corporation Arylsufonamido-substituted hydroxamic acids
US5646167A (en) * 1993-01-06 1997-07-08 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamix acids
US5552419A (en) 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
JPH10501806A (ja) * 1994-06-22 1998-02-17 ブリティッシュ バイオテック ファーマシューティカルズ リミテッド 金属タンパク質分解酵素阻害剤
GB9503749D0 (en) * 1995-02-24 1995-04-12 British Biotech Pharm Synthesis of hydroxamic acid derivatives
US5863949A (en) * 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
DK0757984T3 (da) * 1995-08-08 2003-03-03 Ono Pharmaceutical Co Hydroxamsyrederivater, der kan anvendes til inhibering af gelatinase
CA2238306A1 (en) * 1995-12-08 1997-06-12 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
CA2242416C (en) 1996-01-23 2006-03-21 Shionogi & Co., Ltd. Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
CN100413859C (zh) * 1996-01-23 2008-08-27 盐野义制药株式会社 磺化的氨基酸衍生物及含有它的金属蛋白酶抑制剂
GB9715962D0 (en) 1996-08-23 1997-10-01 Zeneca Ltd Sulfonamides

Similar Documents

Publication Publication Date Title
JP2000507042A5 (https=)
JP2000509637A5 (https=)
JP2000509635A5 (https=)
JP2001526857A5 (https=)
JP2001515470A5 (https=)
JP2000514276A5 (https=)
JP2002509534A5 (https=)
JP2000509587A5 (https=)
JP2000507369A5 (https=)
JP2000507433A5 (https=)
JP2000508866A5 (https=)
JP2000510793A5 (https=)
JP2000508022A5 (https=)
JP2000508841A5 (https=)
JP2002513409A5 (https=)
JP2000508680A5 (https=)
JP2001526709A5 (https=)
JP2000509804A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2000510969A5 (https=)
JP2000508102A5 (https=)
JP2000508836A5 (https=)
JP2000509818A5 (https=)
JP2000509520A5 (https=)